C18 Glucosyl(β) Ceramide (d18:1/18:0)
| Catalog Number | BL-M001023 |
| CAS Number | 95119-86-1 |
| Description | C18 Glucosyl(β) ceramide, a lipid molecule composed of sphingosine and a fatty acid, serves as a key player in cellular signaling cascades and metabolic pathways. It has been implicated in the pathogenesis of a range of diseases such as cancer, diabetes, and neurodegenerative disorders. Manipulation of the molecular network involving this ceramide entity presents a promising avenue for targeted therapeutic interventions in the aforementioned disease states. |
 | |
| IUPAC Name | N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]octadecanamide |
| Synonyms | D-glucosyl-β-1,1'-N-stearoyl-D-erythro-sphingosine; C18 β-D-glucosyl ceramide; N-(octadecanoyl)-1-β-glucosyl-sphing-4-enine; GlcCer(d18:1/18:0) |
| Molecular Weight | 728.09 |
| Molecular Formula | C42H81NO8 |
| Purity | >99% |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 69.28%, H 11.21%, N 1.92%, O 17.58% |
| Canonical SMILES | CCCCCCCCCCCCCCCCCC(=O)NC(COC1C(C(C(C(O1)CO)O)O)O)C(C=CCCCCCCCCCCCCC)O |
| InChI | InChI=1S/C42H81NO8/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-38(46)43-35(34-50-42-41(49)40(48)39(47)37(33-44)51-42)36(45)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h29,31,35-37,39-42,44-45,47-49H,3-28,30,32-34H2,1-2H3,(H,43,46)/b31-29+/t35-,36+,37?,39+,40?,41?,42+/m0/s1 |
| InChI Key | YMYQEDCYNANIPI-KNSMPFANSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
